News Articles and Montana BioScience Alliance Newsletters

MONTANA BIOSCIENCE ENTERPRISES IN THE NEWS

When future astronauts heading to Mars sit down to a hearty supper in their spaceship, they may dine on a nutritious, meat-like product made from a microbe that Montana State University scientists discovered in a Yellowstone National Park hot spring.

The four-year grant will enable MSU and its partners from across Montana to deliver quality medical, dental and behavioral health care to kids in rural and underserved areas while providing exceptional educational opportunities for MSU students.

In making the announcement, MSU President Waded Cruzado said “During the pandemic, Dr. Carter helped lead a group of MSU faculty, students and staff in significantly increasing Montana’s COVID-19 testing capacity during the pandemic. He oversaw the MSU research enterprise, the state’s largest, when it set records in expenditures in 2020, 2021 and set it on track to set another record this year.”

Montana State University Billings
|
July 13, 2022

Montana State University Billings’ Suzette Nynas, associate professor and department chair for the health and human performance department, was recently inducted into the Montana Athletic Trainers’ Association Hall of Fame.

Montana BioScience Alliance
|
July 10, 2022

Since 2004, approximately 1,200 clinical trials have been conducted in Montana. That’s just one of the facts in the report “Research in Your Backyard: Developing Cures, Creating Jobs – Pharmaceutical Clinical Trials in Montana.” The report was the subject of a recent seminar in Billings sponsored by the Montana BioScience Alliance and the Pharmaceutical Research and Manufacturers of America (PhRMA).

ARTICLES OF INTEREST

When her husband was undergoing cancer treatment, Cindy Perez of Southwest Ranches, Fla., learned about a new blood test that could help find early cancers. The 50-year-old said she felt fine, but her husband urged her to take the test anyway.

National Institutes of Health
|
March 26, 2024

Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this extremely common virus.

BIO.News
|
January 30, 2024

As a new year begins in Congress, the Biotechnology Innovation Organization (BIO) is carrying over many of its legislative priorities from last year.

NIH National Institute on Aging
|
January 18, 2024

Administrative Supplements to Promote Diversity in Research and Development Small Businesses – SBIR/STTR

National Institutes of Health SEED
|
January 18, 2024

Contract Pre-solicitation for R&D that will contribute toward ARPA-H mission needs and SBIR program objectives.

NEWSLETTER

Newsletter
|
May 7, 2024

View the Spring 2024 Newsletter now!

Newsletter
|
February 20, 2024

View the Winter II 2024 Newsletter now!